SS
Therapeutic Areas
Gandeeva Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| GND-323 | Oncology | IND-Enabling |
| GND-02 | Oncology | IND-Enabling |
| GND-03 | Oncology | IND-Enabling |
| GND-04 | Oncology | IND-Enabling |
| iGlues™ Platform | Oncology | Discovery |
Leadership Team at Gandeeva Therapeutics
DK
David Karp
Chief Financial Officer
JC
Jason Crawford
Executive Vice President, Drug Discovery
DW
Donna Wong
Vice President, Human Resources
TC
Tom Ceska
Senior Director, Structural Biology and Cryo‑EM Operations
RS
Robert Sikorski
Chief Medical Officer